The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tyrosine kinase inhibitor (TKI) cessation in advanced non-small-cell lung cancer (aNSCLC) for improved detection of EGFR-mutated (EGFRm) circulating tumor DNA (ctDNA).
 
Samer Tabchi
No Relationships to Disclose
 
Stephanie Forte
Honoraria - Novartis Canada Pharmaceuticals Inc
 
Raafat Alameddine
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Aline Khazaka
No Relationships to Disclose
 
Marie Florescu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche Canada
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Roche
 
Xiaoduan Weng
No Relationships to Disclose
 
Mustapha Tehfe
Honoraria - Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Celgene; Ipsen; Lilly; Merck; Pfizer; Taiho Pharmaceutical
Speakers' Bureau - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Ipsen
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Pfizer; Roche Canada; Sanofi
Research Funding - Merck